Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SOX9
is responsible for campomelic dysplasia (CMPD). Symptoms of CMPD include recurrent apnea, upper respiratory infection, facial features, and shortening of the lower extremities. The variant acampomelic CMPD (ACMPD) lacks long bone curvature. A patient showed macrocephaly (+3.9 standard deviations [SD]) and minor anomalies, such as hypertelorism, palpebronasal fold, small mandible, and a cleft of soft palate without long bone curvature. From three months of age, he required tracheal intubation and artificial respiration under sedation because of tracheomalacia. Cranial magnetic resonance imaging was normal at one month of age but showed ventriculomegaly, hydrocephaly, and the corpus callosum
thinning
at two years of age. Exome sequencing revealed a de novo novel mutation, c. 236A>C, p (Q79P), in
SOX9
. Sox9 is thought to be crucial in neural stem cell development in the central and peripheral nervous system along with Sox8 and Sox10 in mice. In humans, neuronal abnormalities have been reported in cases of CMPD and ACMPD, including relative macrocephaly in 11 out of 22 and mild lateral ventriculomegaly in 2 out of 22 patients. We encountered a two-year old boy with ACMPD presenting with tracheomalacia and macrocephaly with a
SOX9
mutation. We described for the first time an ACMPD patient with acquired diminished white matter and corpus callosal
thinning
, indicating the failure of oligodendrocyte/astrocyte development postnatally. This phenotype suggests that
SOX9
plays a crucial role in human central nervous system development. Further cases are needed to clarify the relationship between human neural development and
SOX9
mutations.
...
PMID:The presence of diminished white matter and corpus callosal thinning in a case with a SOX9 mutation. 2896 76
Campomelic dysplasia is a rare skeletal dysplasia characterized by Pierre Robin sequence, craniofacial dysmorphism, shortening and angulation of long bones, tracheobronchomalacia, and occasionally sex reversal. The disease is due to mutations in
SOX9
or chromosomal rearrangements involving the long arm of Chromosome 17 harboring the
SOX9
locus.
SOX9
, a transcription factor, is indispensible in establishing and maintaining neural stem cells in the central nervous system. We present a patient with angulation of long bones and external female genitalia on prenatal ultrasound who was subsequently found to harbor the chromosomal abnormality 46, XY, t(6;17) (p21.1;q24.3) on prenatal genetic testing. Comparative genomic hybridization revealed deletions at 6p21.1 and 17q24.3, the latter being 2.3 Mb upstream of
SOX9
Whole-exome sequencing did not identify pathogenic variants in
SOX9
, suggesting that the 17q24.3 deletion represents a translocation breakpoint farther upstream of
SOX9
than previously identified. At 2 mo of age the patient developed progressive communicating ventriculomegaly and
thinning
of the cortical mantle without clinical signs of increased intracranial pressure. This case suggests ventriculomegaly in some cases represents not a primary impairment of cerebrospinal fluid dynamics, but an epiphenomenon driven by a genetic dysregulation of neural progenitor cell fate.
...
PMID:A novel association of campomelic dysplasia and hydrocephalus with an unbalanced chromosomal translocation upstream of
SOX9
. 2969 6